{"transactions":[{"id":2515099,"issuer":{"id":1570,"kind":"organization","name":"Doximity, Inc.","symbol":"DOCS"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2021-11-12T16:43:26.000Z","date":"2021-11-10","kind":"exercise","acquired":false,"shares":17070350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Conversion of a derivative security in accordance of its terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Morgenthaler Venture Partners IX, L.P. (\"Morgenthaler\"). Morgenthaler Management Partners IX, LLC (\"MMP IX\") is the sole general partner of Morgenthaler. MMP IX may be deemed to indirectly beneficially own the shares held by Morgenthaler, and MMP IX disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":17070350},"source":{"system":"sec-edgar","filing":"0001104659-21-138151","document":"tm2129009-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465921138151/tm2129009-14_4seq1.xml","form_type":"4"}},{"id":2515098,"issuer":{"id":1570,"kind":"organization","name":"Doximity, Inc.","symbol":"DOCS"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-12T16:43:26.000Z","date":"2021-11-12","kind":"other","acquired":false,"shares":8535175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata, in-kind distribution by Morgenthaler and its affiliated funds, not for additional consideration, to MMP IX and its respective members and assignees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Morgenthaler Venture Partners IX, L.P. (\"Morgenthaler\"). Morgenthaler Management Partners IX, LLC (\"MMP IX\") is the sole general partner of Morgenthaler. MMP IX may be deemed to indirectly beneficially own the shares held by Morgenthaler, and MMP IX disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein."}],"balance_after":8535175,"source":{"system":"sec-edgar","filing":"0001104659-21-138151","document":"tm2129009-14_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465921138151/tm2129009-14_4seq1.xml","form_type":"4"}},{"id":2515097,"issuer":{"id":1570,"kind":"organization","name":"Doximity, Inc.","symbol":"DOCS"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-12T16:43:26.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":17070350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Conversion of a derivative security in accordance of its terms."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Morgenthaler Venture Partners IX, L.P. (\"Morgenthaler\"). Morgenthaler Management Partners IX, LLC (\"MMP IX\") is the sole general partner of Morgenthaler. MMP IX may be deemed to indirectly beneficially own the shares held by Morgenthaler, and MMP IX disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein."}],"balance_after":17070350,"source":{"system":"sec-edgar","filing":"0001104659-21-138151","document":"tm2129009-14_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465921138151/tm2129009-14_4seq1.xml","form_type":"4"}},{"id":2653462,"issuer":{"id":1570,"kind":"organization","name":"Doximity, Inc.","symbol":"DOCS"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-06-28T18:15:39.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":17070350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by Morgenthaler Venture Partners IX, L.P. (\"Morgenthaler\").  Morgenthaler Management Partners IX, LLC (\"MMP IX\") is the sole general partner of Morgenthaler.  MMP IX may be deemed to indirectly beneficially own the shares held by Morgenthaler, and MMP IX disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein."}],"balance_after":17070350,"derivative":{"underlying":"Class A Common Stock","underlying_shares":17070350},"source":{"system":"sec-edgar","filing":"0001628280-21-013073","document":"wf-form4_162491849600661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000162828021013073/wf-form4_162491849600661.xml","form_type":"4"}},{"id":2653461,"issuer":{"id":1570,"kind":"organization","name":"Doximity, Inc.","symbol":"DOCS"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-06-28T18:15:39.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":1659476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by Morgenthaler Venture Partners IX, L.P. (\"Morgenthaler\").  Morgenthaler Management Partners IX, LLC (\"MMP IX\") is the sole general partner of Morgenthaler.  MMP IX may be deemed to indirectly beneficially own the shares held by Morgenthaler, and MMP IX disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1659476},"source":{"system":"sec-edgar","filing":"0001628280-21-013073","document":"wf-form4_162491849600661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000162828021013073/wf-form4_162491849600661.xml","form_type":"4"}},{"id":2653460,"issuer":{"id":1570,"kind":"organization","name":"Doximity, Inc.","symbol":"DOCS"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-28T18:15:39.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":15410874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the \"Preferred Stock\") automatically converted into one share of Class B Common Stock, par value $0.001 per share (the \"Class B Common Stock\"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering (\"IPO\"). The shares of Preferred Stock have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock, par value $0.001 per share (the \"Class A Common Stock\"), at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by Morgenthaler Venture Partners IX, L.P. (\"Morgenthaler\").  Morgenthaler Management Partners IX, LLC (\"MMP IX\") is the sole general partner of Morgenthaler.  MMP IX may be deemed to indirectly beneficially own the shares held by Morgenthaler, and MMP IX disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":15410874},"source":{"system":"sec-edgar","filing":"0001628280-21-013073","document":"wf-form4_162491849600661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000162828021013073/wf-form4_162491849600661.xml","form_type":"4"}},{"id":3756531,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Convertible Preferred Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":61342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series D-1 Convertible Preferred Stock automatically converted into 1.137 shares of Common Stock without payment or further consideration. There was no expiration date for the Series D-1 Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series D-1 Convertible Preferred Stock automatically converted into 1.137 shares of Common Stock without payment or further consideration. There was no expiration date for the Series D-1 Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series D-1 Convertible Preferred Stock automatically converted into 1.137 shares of Common Stock without payment or further consideration. There was no expiration date for the Series D-1 Convertible Preferred Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":61342},"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":3756530,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":129418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":129418},"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":3756529,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":359842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":359842},"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":3756528,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":217803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":217803},"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":3756527,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":214285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":214285},"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":3756526,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":true,"shares":61342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of Series D-1 Convertible Preferred Stock automatically converted into 1.137 shares of Common Stock without payment or further consideration. There was no expiration date for the Series D-1 Convertible Preferred Stock."}],"balance_after":982690,"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":3756525,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-20T17:09:47.000Z","date":"2018-11-16","kind":"exercise","acquired":true,"shares":921348,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock."}],"balance_after":921348,"source":{"system":"sec-edgar","filing":"0000899243-18-029477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000089924318029477/doc4.xml","form_type":"4"}},{"id":4571982,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"exercise","acquired":false,"shares":3408439,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the Series B-2 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of the Series B-2 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the Series B-2 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the Series B-2 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":486919},"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571981,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"exercise","acquired":false,"shares":3664071,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of the Series B-1 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of the Series B-1 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of the Series B-1 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of the Series B-1 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":523438},"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571980,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"exercise","acquired":false,"shares":9744916,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Series A Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Series A Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Series A Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Series A Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1392130},"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571979,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"other","acquired":false,"shares":63019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Warrants were automatically exercised immediately prior to the closing of the Issuer's initial public offering for such number of shares issuable pursuant to a cashless net exercise provision, resulting in the Issuer withholding 340 of the warrant shares to pay the aggregate exercise price, using the offering price in the Issuer's initial public offering of $13.00, and issuing to the reporting person the remaining 62,679 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants were automatically exercised immediately prior to the closing of the Issuer's initial public offering for such number of shares issuable pursuant to a cashless net exercise provision, resulting in the Issuer withholding 340 of the warrant shares to pay the aggregate exercise price, using the offering price in the Issuer's initial public offering of $13.00, and issuing to the reporting person the remaining 62,679 shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.07,"expiration_date":"2022-04-01","underlying":"Common Stock","underlying_shares":63019},"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571978,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"purchase","acquired":true,"shares":263538,"price":13,"value":3425994.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":2745846,"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571977,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"exercise","acquired":true,"shares":486919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of the Series B-2 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":2482308,"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571976,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"exercise","acquired":true,"shares":523438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of the Series B-1 Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":1995389,"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571975,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"exercise","acquired":true,"shares":1392130,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Series A Preferred Stock converted into Common Stock on a 1-for-7 basis automatically and without additional consideration upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":1471951,"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571974,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"sale","acquired":false,"shares":340,"price":13,"value":4420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Warrants were automatically exercised immediately prior to the closing of the Issuer's initial public offering for such number of shares issuable pursuant to a cashless net exercise provision, resulting in the Issuer withholding 340 of the warrant shares to pay the aggregate exercise price, using the offering price in the Issuer's initial public offering of $13.00, and issuing to the reporting person the remaining 62,679 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Warrants were automatically exercised immediately prior to the closing of the Issuer's initial public offering for such number of shares issuable pursuant to a cashless net exercise provision, resulting in the Issuer withholding 340 of the warrant shares to pay the aggregate exercise price, using the offering price in the Issuer's initial public offering of $13.00, and issuing to the reporting person the remaining 62,679 shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":79821,"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}},{"id":4571973,"issuer":{"id":150034,"kind":"organization","name":"Ra Pharmaceuticals, Inc.","symbol":"RARX"},"owners":[{"id":133568,"kind":"organization","name":"MORGENTHALER VENTURE PARTNERS IX LP","position":1,"cik":"0001439101","reported_name":"MORGENTHALER VENTURE PARTNERS IX LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120053,"kind":"organization","name":"Morgenthaler Management Partners IX, LLC","position":2,"cik":"0001666860","reported_name":"Morgenthaler Management Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T16:51:59.000Z","date":"2016-10-31","kind":"other","acquired":true,"shares":63019,"price":0.07,"value":4411.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Warrants were automatically exercised immediately prior to the closing of the Issuer's initial public offering for such number of shares issuable pursuant to a cashless net exercise provision, resulting in the Issuer withholding 340 of the warrant shares to pay the aggregate exercise price, using the offering price in the Issuer's initial public offering of $13.00, and issuing to the reporting person the remaining 62,679 shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are held by Morgenthaler Venture Partners IX, L.P. (\"MVP IX\"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC (\"MMP IX\"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX.  MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein."}],"balance_after":80161,"source":{"system":"sec-edgar","filing":"0001104659-16-153349","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666860/000110465916153349/a4.xml","form_type":"4"}}]}